Menu Search
Equities

Phreesia Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
19P:DUS

Phreesia Inc

Actions
  • Price (EUR)10.30
  • Today's Change-0.32 / -3.01%
  • Shares traded--
  • 1 Year change-62.95%
  • Beta0.6677
Data delayed at least 15 minutes, as of Feb 06 2026 18:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

  • Revenue in USD (TTM)463.21m
  • Net income in USD-5.38m
  • Incorporated2005
  • Employees2.08k
  • Location
    Phreesia Inc1521 Concord Pike, Suite 301 Pmb 221WILMINGTON 19803United StatesUSA
  • Phone+1 (646) 747-9959
  • Fax+1 (646) 607-1776
  • Websitehttps://www.phreesia.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		PHR:NYQ since
announced		Transaction
value
AccessOne Parent Holdings IncDeal completed04 Sep 202504 Sep 2025Deal completed-59.92%163.00m
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.